UBE2V1 and metabolic dysfunction-associated steatotic liver disease: Interestingly UBE2V1, RP11‐128N14.5, TGFB2/TGFB2‐OT1 were up‐regulated in severe NAFLD patient with respect to mild NAFLD and controls.